Your browser doesn't support javascript.
Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection. / El suplemento con altas dosis de vitaminaD podría representar una alternativa promisoria para prevenir o tratar la infección por COVID-19.
Mansur, José Luis; Tajer, Carlos; Mariani, Javier; Inserra, Felipe; Ferder, León; Manucha, Walter.
  • Mansur JL; Centro de Endocrinología y Osteoporosis, La Plata, Buenos Aires, Argentina.
  • Tajer C; Hospital de Alta Complejidad El Cruce, Buenos Aires, Argentina.
  • Mariani J; Hospital de Alta Complejidad El Cruce, Buenos Aires, Argentina.
  • Inserra F; Universidad Maimónides, Ciudad Autónoma de Buenos Aires, Argentina.
  • Ferder L; Universidad Maimónides, Ciudad Autónoma de Buenos Aires, Argentina.
  • Manucha W; Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza, CONICET, Mendoza, Argentina; Laboratorio de Farmacología Experimental, Básica y Traslacional, Área de Farmacología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina. Electronic address: wmanuch
Clin Investig Arterioscler ; 32(6): 267-277, 2020.
Article in English, Spanish | MEDLINE | ID: covidwho-688941
ABSTRACT
Although we lack enough evidence to justify supplementing with vitaminD in the prevention and treatment of COVID-19 infection, it is increasingly feasible that this hypothesis is valid. Two general underlying mechanisms should be considered. One would be the anti-infectious and immunomodulatory action that it exerts by improving intercellular barriers by stimulating innate immunity, as well as by modulating adaptive immunity. Also, vitaminD reduces the production of inflammatory cytokines, such as IL-2 and interferon-gamma (INF-γ). More recently, multiple pleiotropic effects have been demonstrated on the actions of vitaminD at the anti-inflammatory and immunomodulatory level with positive results in studies with influenza, coronavirus, and other respiratory infections. An inverse relationship between serum vitaminD levels and the prevalence of the respiratory infectious disease has been described. Of interest, another mechanistic approach responds to considering the inhibition of the renin-angiotensin-aldosterone system (RAAS), which is exacerbated in COVID-19 infection because the virus binds to the enzyme ACE2, making more angiotensinII available to cause damage. VitaminD inhibits mediators of RAAS - present in all cells of the body - and by inhibiting ACE activity and increasing ACE2, it lowers angiotensinII levels. We present studies with proposals for recommended doses of vitaminD, and although a single guideline is not specified, the possible benefits are promising. Finally, the purpose of this review is to share this idea with health professionals to ignite the debate and call for critical reflection, so that it can contribute to the undertaking of more and better clinical designs to validate the benefits of using high doses of vitaminD for the benefit of public health and especially in times of crisis for COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitamin D / Vitamins / Dietary Supplements / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study Topics: Traditional medicine Limits: Humans Language: English / Spanish Journal: Clin Investig Arterioscler Year: 2020 Document Type: Article Affiliation country: J.arteri.2020.05.003

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitamin D / Vitamins / Dietary Supplements / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study Topics: Traditional medicine Limits: Humans Language: English / Spanish Journal: Clin Investig Arterioscler Year: 2020 Document Type: Article Affiliation country: J.arteri.2020.05.003